Improving Outcomes with Chemoradiotherapy in the Mucosal Squamous Cell Carcinomas - Immune Checkpoint Inhibition and Broken Promises.

Samuel, R; Samson, A; Gilbert, D C

Samuel, R; Samson, A; Gilbert, D C.

Afiliação

Samuel R; Leeds Institute for Medical Research, University of Leeds, Leeds, UK; Manchester Cancer Research Centre, National Institute of Health and Research Manchester Biomedical Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, And Health, University of Manchester, Manchester, UK.
Samson A; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Gilbert DC; MRC Clinical Trials Unit at UCL, London, UK; Sussex Cancer Centre, University Hospitals Sussex NHS Foundation Trust, Royal Sussex County Hospital, Brighton, UK. Electronic address: duncan.gilbert@ucl.ac.uk.

Clin Oncol (R Coll Radiol) ; 35(12): 764-768, 2023 12.

Article em En | MEDLINE | ID: mdl-37743210

Assuntos

Carcinoma de Células Escamosas; Neoplasias Esofágicas; Humanos; Inibidores de Checkpoint Imunológico; Carcinoma de Células Escamosas/tratamento farmacológico; Carcinoma de Células Escamosas/radioterapia; Quimiorradioterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas Limite: Humans Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google